Gut microbiome and liver disease
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Gut microbiota changes are important in determining the occurrence and progression of chronic liver disease related to alcohol, non-alcoholic fatty liver disease and cirrhosis. Specifically the systemic inflammation, endotoxemia and the vasodilation that leads to complications such as spontaneous bacterial peritonitis and hepatic encephalopathy could be related to the gut milieu. Given the poor prognosis of these events, their prevention and early management are essential. Microbiota may be essential component of the gut milieu that can impact these clinical events and the study of their composition and function in a culture-independent manner could help understand the prognosis. Recent human and animal studies have shown that the relative abundance and the functional changes of microbiota in the stool, colonic mucosa and saliva have varying consequences on the presence and prognosis of chronic liver disease and cirrhosis. The impact of therapies on the microbiota is slowly being understood and will likely lead to a more targeted approach to gut microbiota modification in chronic liver disease and cirrhosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597 · cited 1×
“This dy biosis can lead to obesity (25) (26) , metabolic syndromes (27) , diabetes (28) (29), card iovascular diseases (30), Nonalcoholic Fatty Liver Disease (NAFLD) (31), Nonalcoholic steatohep atitis (NASH) (32) Alcoholic Liver Diseases (33).”
BackgroundHost-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760 · cited 1×
“The severity of these di ases aggravates due to promotion of bacterial translocation (BT) from the gut to the sy stemic circulation leading to the severity of these infections (35).”
BackgroundPrevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
Larsen, N., Vogensen, F. K., van den Berg, F. W. J., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., Al-Soud, W. A., Sørensen, S. J., Hansen, L. H., & Jakobsen, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009085 · Cited by 2,952 · cited 1×
“This dy biosis can lead to obesity (25) (26) , metabolic syndromes (27) , diabetes (28) (29), card iovascular diseases (30), Nonalcoholic Fatty Liver Disease (NAFLD) (31), Nonalcoholic steatohep atitis (NASH) (32) Alcoholic Liver Diseases (33).”
BackgroundVrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R. S., Bartelsman, J. F. W. M., Dallinga–Thie, G. M., Ackermans, M. T., Serlie, M. J., Oozeer, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.031 · Cited by 2,913
UniFrac: an effective distance metric for microbial community comparison
Lozupone, C., Lladser, M. E., Knights, D., Stombaugh, J., & Knight, R. (2011) · The ISME Journal · doi:10.1038/ismej.2010.133 · Cited by 2,825
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581 · cited 1×
“Non-alcoholic fatty liver disease (NAFLD) NAFLD is the liver manifestation of the metabolic s yndrome and encompasses a spectrum of hepatic pathology (54).”
BackgroundInflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435 · cited 1×
“A mouse model deficient in pro-inflammatory multi-p rotein complexes, termed inflammasomes was used in this study (59).”
MethodCommensal Host-Bacterial Relationships in the Gut
Hooper, L. V., & Gordon, J. I. (2001) · Science · doi:10.1126/science.1058709 · Cited by 2,362
Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237 · cited 1×
“In a human s tudy (130) with noncirrhotic, nonalcoholic steatohepatitis patients, obeticholic acid was rece ntly shown to improve liver fibrosis.”
BackgroundMolecular Analysis of Commensal Host-Microbial Relationships in the Intestine
Hooper, L. V., Wong, M. H., Thelin, A., Hansson, L., Falk, P. G., & Gordon, J. I. (2001) · Science · doi:10.1126/science.291.5505.881 · Cited by 2,202 · cited 1×
“fermentation (15), the biochemical capabilities of the microbiota mediates beneficial roles including but not limited to vitamin synthesis, bil e salt metabolism, processing of xenobiotic degradation and angiogenesis, regulation of postnat al maturation, (16) (17).”
BackgroundDietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice
Devkota, S., Wang, Y., Musch, M. W., Leone, V., Fehlner-Peach, H., Nadimpalli, A., Antonopoulos, D. A., Jabri, B., & Chang, E. B. (2012) · Nature · doi:10.1038/nature11225 · Cited by 1,904
Zhu, L., Baker, S. S., Gill, C., Liu, W., Alkhouri, R., Baker, R. D., & Gill, S. R. (2013) · Hepatology · doi:10.1002/hep.26093 · Cited by 1,708 · cited 2×
“This dy biosis can lead to obesity (25) (26) , metabolic syndromes (27) , diabetes (28) (29), card iovascular diseases (30), Nonalcoholic Fatty Liver Disease (NAFLD) (31), Nonalcoholic steatohep atitis (NASH) (32) Alcoholic Liver Diseases (33).”
BackgroundMethodAn ecological and evolutionary perspective on human–microbe mutualism and disease
Dethlefsen, L., McFall-Ngai, M., & Relman, D. A. (2007) · Nature · doi:10.1038/nature06245 · Cited by 1,660
Boursier, J., Mueller, O., Barret, M., Machado, M., Fizanne, L., Araujo‐Perez, F., Guy, C. D., Seed, P. C., Rawls, J. F., David, L. A., et al. (2016) · Hepatology · doi:10.1002/hep.28356 · Cited by 1,483 · cited 1×
“To study the gut dysbiosis in the spectrum of NAFLD lesions (65), 57 patients with biopsy proven NAFLD were enrolled.”
BackgroundRifaximin Treatment in Hepatic Encephalopathy
Bass, N. M., Mullen, K. D., Sanyal, A., Poordad, F., Neff, G., Leevy, C. B., Sigal, S., Sheikh, M. Y., Beavers, K., Frederick, T., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907893 · Cited by 1,300
Altered profile of human gut microbiome is associated with cirrhosis and its complications
Bajaj, J. S., Heuman, D. M., Hylemon, P. B., Sanyal, A. J., White, M. B., Monteith, P., Noble, N. A., Unser, A. B., Daita, K., Fisher, A. R., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.019 · Cited by 1,099 · cited 4×
“In humans with cirrhosis admitted with infections such as SBP , there was inherent pre-existing gut dysbiosis that was significantly worse in MELD-matched uninfe cted patients and healthy controls (73).”
BackgroundInfluentialSelf-citationDumas, M.-E., Barton, R. H., Toye, A., Cloarec, O., Blancher, C., Rothwell, A., Fearnside, J., Tatoud, R., Blanc, V., Lindon, J. C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601056103 · Cited by 1,042 · cited 1×
“Metagenomic approaches help recognize biochemical processes, me tabolic conditions in non–insulin dependent diabetes, nonalcoholic steatosis, and ath erosclerosis linking the changes to the microbial population (50) and this data can be inte rpreted by using the bioinformatics methods and also predict the metabolic in…”
MethodIntestinal microbiota determines development of non-alcoholic fatty liver disease in mice
Le Roy, T., Llopis, M., Lepage, P., Bruneau, A., Rabot, S., Bevilacqua, C., Martin, P., Philippe, C., Walker, F., Bado, A., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-303816 · Cited by 1,001
Leclercq, S., Matamoros, S., Cani, P. D., Neyrinck, A. M., Jamar, F., Stärkel, P., Windey, K., Tremaroli, V., Bäckhed, F., Verbeke, K., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415174111 · Cited by 972 · cited 1×
“Human studies in pre-cirrhotic alcohol use have sho wn that gut leakiness and bacterial composition changes after short-term alcohol cessat ion (80).”
BackgroundInteractions Between the Intestinal Microbiome and Liver Diseases
Schnabl, B., & Brenner, D. A. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.020 · Cited by 971 · cited 1×
“The interaction b etween the microbiome and the host liver is of special interest in alcoholic liver diseases where alcohol has shown to change the composition of the microbiome and affect the intestinal integrity and barrier function (70) (71).”
BackgroundCorr, S. C., Li, Y., Riedel, C. U., O'Toole, P. W., Hill, C., & Gahan, C. G. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700440104 · Cited by 853
Colonic microbiome is altered in alcoholism
Mutlu, E. A., Gillevet, P. M., Rangwala, H., Sikaroodi, M., Naqvi, A., Engen, P. A., Kwasny, M., Lau, C. K., & Keshavarzian, A. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00380.2011 · Cited by 775 · cited 1×
“To study the effects of colonic bacteria on alcohol c nsumption, a study (81) evaluated the alterations in colonic microbiome in 48 alcoholics with and without ALD and compared this to 18 healthy subjects.”
MethodSelf-citationIntestinal microbiota in patients with nonalcoholic fatty liver disease
Mouzaki, M., Comelli, E. M., Arendt, B. M., Bonengel, J., Fung, S. K., Fischer, S. E., McGilvray, I. D., & Allard, J. P. (2013) · Hepatology · doi:10.1002/hep.26319 · Cited by 749 · cited 1×
“In a cross-sectional study to differentiate subject s based on their IM (67), 11 subjects with biopsy-proven simple steatosis, 22 NASH and 17 livi ng liver donors as healthy controls were recruited.”
BackgroundDel Chierico, F., Nobili, V., Vernocchi, P., Russo, A., De Stefanis, C., Gnani, D., Furlanello, C., Zandonà, A., Paci, P., Capuani, G., et al. (2017) · Hepatology · doi:10.1002/hep.28572 · Cited by 696
Bacterial translocation (BT) in cirrhosis†
Wiest, R., & Garcia‐Tsao, G. (2005) · Hepatology · doi:10.1002/hep.20632 · Cited by 677 · cited 10×
“In humans with cirrhosis admitted with infections such as SBP, there was inherent pre-existing gut dysbiosis that was significantly worse in MELD-matched uninfected patients and healthy controls (73).”
BackgroundInfluentialRaman, M., Ahmed, I., Gillevet, P. M., Probert, C. S., Ratcliffe, N. M., Smith, S., Greenwood, R., Sikaroodi, M., Lam, V., Crotty, P., et al. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.02.015 · Cited by 672 · cited 1×
“To compare the colonic microbiome and volatile orga nic compounds (VOC), the authors (68) recruited 30 NAFLD patients and 30 healthy controls .”
BackgroundSelf-citationExcess weight risk factor for alcoholic liver disease
Naveau, S., Giraud, V., Borotto, E., Aubert, A., Capron, F., & Chaput, J. (1997) · Hepatology · doi:10.1002/hep.510250120 · Cited by 666 · cited 1×
“Various factors have been associated with the progression of ALD including duration of alcohol abuse, obesity, pre-existing underlying liv er disease such as hepatic C infection (7) (8) (9).”
BackgroundGinés, P., Rimola, A., Planas, R., Vargas, V., Marco, F., Almela, M., Forne, M., Miranda, M. L., Llach, J., Salmerón, J. M., et al. (1990) · Hepatology · doi:10.1002/hep.1840120416 · Cited by 627 · cited 9×
“In humans with cirrhosis admitted with infections such as SBP, there was inherent pre-existing gut dysbiosis that was significantly worse in MELD-matched uninfected patients and healthy controls (73).”
BackgroundInfluentialSpencer, M. D., Hamp, T. J., Reid, R. W., Fischer, L. M., Zeisel, S. H., & Fodor, A. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.11.049 · Cited by 593
Linkage of gut microbiome with cognition in hepatic encephalopathy
Bajaj, J. S., Ridlon, J. M., Hylemon, P. B., Thacker, L. R., Heuman, D. M., Smith, S., Sikaroodi, M., & Gillevet, P. M. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00190.2011 · Cited by 547 · cited 2×
“This was shown in human HE studies, where a higher relative abundance of Enterobacteriaceae, Alcaligeneceae, and Fusobacteriaceae and lower abundances of Ruminococcaceae, Lachnospiraceae was shown in cirrhosis (104) (105).”
BackgroundResultSelf-citationIncreased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia
Guarner, C., Soriano, G., Tomas, A., Bulbena, O., Novella, M. T., Balanzo, J., Vilardell, F., Mourelle, M., & Moncada, S. (1993) · Hepatology · doi:10.1002/hep.1840180520 · Cited by 489
Vollaard, E. J., & Clasener, H. A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.3.409 · Cited by 478 · cited 1×
“This colonization resistance helps fight many infections (23) (24).”
Bajaj, J. S., Heuman, D. M., Sanyal, A. J., Hylemon, P. B., Sterling, R. K., Stravitz, R. T., Fuchs, M., Ridlon, J. M., Daita, K., Monteith, P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060042 · Cited by 430 · cited 1×
“This study (116) has also shown that rifaximin has a direct effect o n bacterial function by impairing their ability to translocate.”
BackgroundLumsden, A. B., Henderson, M. J., & Kutner, M. H. (1988) · Hepatology · doi:10.1002/hep.1840080207 · Cited by 427 · cited 1×
“Activation of NO and increased s erum levels contributes to systemic vasodilation, increased cardiac output, decreased m an arterial pressure and is responsible for variceal growth, ascites and hepatorenal syndrome (94) (95).”
BackgroundBajaj, J. S., O'Leary, J. G., Reddy, K. R., Wong, F., Olson, J. C., Subramanian, R. M., Brown, G., Noble, N. A., Thacker, L. R., Kamath, P. S., et al. (2012) · Hepatology · doi:10.1002/hep.25947 · Cited by 413
Self-citationCatecholamine induced growth of gram negative bacteria
Lyte, M., & Ernst, S. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90273-r · Cited by 396
Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease
Michail, S., Lin, M., Frey, M. R., Fanter, R., Paliy, O., Hilbush, B., & Reo, N. V. (2015) · FEMS Microbiology Ecology · doi:10.1093/femsec/fiu002 · Cited by 336
Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy
Bajaj, J. S., Betrapally, N. S., Hylemon, P. B., Heuman, D. M., Daita, K., White, M. B., Unser, A., Thacker, L. R., Sanyal, A. J., Kang, D. J., et al. (2015) · Hepatology · doi:10.1002/hep.27819 · Cited by 325 · cited 2×
“Interestingly, not only the gut-liver axis, but als o alivary inflammation and microbiota have been found to be impaired in patients with cirrhosi s (53).”
BackgroundMethodSelf-citationChen, P., Torralba, M., Tan, J., Embree, M., Zengler, K., Stärkel, P., van Pijkeren, J.-P., DePew, J., Loomba, R., Ho, S. B., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.09.014 · Cited by 322 · cited 1×
“ACLF and outcomes can be predicted by microbiota: M icrobial profile can predict the occurrence of organ failures and death in hospitali zed cirrhotic patients (73) (74).”
BackgroundSelf-citationPérez-Paramo, M., Muñoz, J., Albillos, A., Freile, I., Portero, F., Santos, M., & Ortiz-Berrocal, J. (2000) · Hepatology · doi:10.1002/hep.510310109 · Cited by 271 · cited 1×
“Propr anolol has been shown to significantly accelerate intestinal transit, reduce rates of bact eri l overgrowth in the bowel and bacterial translocation (127).”
BackgroundDeficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice
Hartmann, P., Chen, P., Wang, H. J., Wang, L., McCole, D. F., Brandl, K., Stärkel, P., Belzer, C., Hellerbrand, C., Tsukamoto, H., et al. (2013) · Hepatology · doi:10.1002/hep.26321 · Cited by 246 · cited 1×
“Experimental alcohol induced liver disease was stud ied (75) in a Tsukamoto-French method in wild type and Muc2 -/- mice to investigate the role intestinal mucus laye r.”
MethodVerbeke, L., Farre, R., Verbinnen, B., Covens, K., Vanuytsel, T., Verhaegen, J., Komuta, M., Roskams, T., Chatterjee, S., Annaert, P., et al. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.10.009 · Cited by 225 · cited 1×
“Studies (129) in FXRdeficient rats exhibit bacterial translocation and intestinal permeability.”
BackgroundVlachogiannakos, J., Viazis, N., Vasianopoulou, P., Vafiadis, I., Karamanolis, D. G., & Ladas, S. D. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12070 · Cited by 206
Stimulation of bacterial growth by heat-stable, norepinephrine-induced autoinducers
Freestone, P. P. E., Haigh, R. D., Williams, P. H., & Lyte, M. (1999) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1999.tb13449.x · Cited by 199 · cited 1×
“β-blockers may act as an antibacterial targeting mec hanisms responsible for bacterial translocation in cirrhosis by blocking norepinephri ne which helps the growth of Gram-negative rods and intestinal permeability (125) (126).”
BackgroundRifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases
Koo, H. L., & DuPont, H. L. (2010) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328333dc8d · Cited by 189 · cited 1×
“Rifaximin is a broad spectrum bacteria that w s used to reduce the overall burden of intestinal microbiota by non-selectively eliminatin g gut microbes (114) (115).”
BackgroundSmall‐intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease
PANDE, C., KUMAR, A., & SARIN, S. K. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.03994.x · Cited by 152 · cited 1×
“Bacterial overgrowth of the small intestine is prom inent in cirrhotic rats with ascites and patients with cirrhosis and is thought to be the most common site of bacterial translocation (111) (112) (113).”
BackgroundBajaj, J. S., Cox, I. J., Betrapally, N. S., Heuman, D. M., Schubert, M. L., Ratneswaran, M., Hylemon, P. B., White, M. B., Daita, K., Noble, N. A., et al. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00268.2014 · Cited by 143
Self-citationThe gut microbiota and the liver. Pathophysiological and clinical implications
Quigley, E. M. M., Stanton, C., & Murphy, E. F. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.023 · Cited by 133
The impact of obesity and metabolic syndrome on alcoholic liver disease
Chiang, D. J., & McCullough, A. J. (2014) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.09.006 · Cited by 99 · cited 1×
“Various factors have been associated with the progression of ALD including duration of alcohol abuse, obesity, pre-existing underlying liv er disease such as hepatic C infection (7) (8) (9).”
BackgroundCytokine response of human mononuclear cells induced by intestinal Clostridium species
Tuovinen, E., Keto, J., Nikkilä, J., Mättö, J., & Lähteenmäki, K. (2013) · Anaerobe · doi:10.1016/j.anaerobe.2012.11.002 · Cited by 75
Francés, R., Chiva, M., Sánchez, E., González-Navajas, J. M., Llovet, T., Zapater, P., Soriano, G., Muñoz, C., Balanzó, J., Pérez-Mateo, M., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2006.11.018 · Cited by 54 · cited 6×
“Another murine study (58), the fecal samples were colle ted from mice on a high fat diet that demonstrated weight gain with increase systemic inflammation (increased serum levels of MCP1 and TNF-α) and the fecal transfer to germ-free mice exhibited the phenotypic features of their donors.”
BackgroundInfluential
Cited by
Gut Microbiota: An Integral Moderator in Health and Disease
Feng, Q., Chen, W.-D., & Wang, Y.-D. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00151 · Cited by 407
“The gut microbiota may modulate alcohol liver disease (ALD), non-alcoholic fatty liver disease (NAFLD), cirrhosis, and even hepatic carcinoma (Betrapally et al., 2017).”
BackgroundEngelmann, C., Clària, J., Szabo, G., Bosch, J., & Bernardi, M. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.01.002 · Cited by 400
Scorletti, E., Afolabi, P. R., Miles, E. A., Smith, D. E., Almehmadi, A., Alshathry, A., Childs, C. E., Del Fabbro, S., Bilson, J., Moyses, H. E., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.031 · Cited by 237
Gut–liver axis, cirrhosis and portal hypertension: the chicken and the egg
Arab, J. P., Martin-Mateos, R. M., & Shah, V. H. (2018) · Hepatology International · doi:10.1007/s12072-017-9798-x · Cited by 227
Role of cAMP and phosphodiesterase signaling in liver health and disease
Wahlang, B., McClain, C., Barve, S., & Gobejishvili, L. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.06.005 · Cited by 168
Metadata
- Authors
- Betrapally, N. S., Gillevet, P. M., & Bajaj, J. S.
- Venue
- Translational Research
- Publisher
- Elsevier BV
- Published
- 2017-01
- Volume
- 179
- Pages
- 49-59
- ISSN
- 1878-1810 (ISSN-L)
- 1931-5244
- OpenAlex
- W2467065439
- Cited by
- 103
- References
- 52
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.